€73.30
0.41% yesterday
Paris, Jun 27, 05:35 pm CET
ISIN
FR0004186856
Symbol
VETO
Sector
Industry

Vetoquinol Stock price

€73.30
+0.50 0.69% 1M
-4.60 5.91% 6M
-1.60 2.14% YTD
-22.40 23.41% 1Y
-45.30 38.20% 3Y
+12.30 20.16% 5Y
+36.30 98.11% 10Y
+50.30 218.70% 20Y
Paris, Closing price Fri, Jun 27 2025
+0.30 0.41%
ISIN
FR0004186856
Symbol
VETO
Sector
Industry

Key metrics

Basic
Market capitalization
€863.3m
Enterprise Value
€678.1m
Net debt
€-185.2m
Cash
€206.3m
Shares outstanding
11.8m
Valuation (TTM | estimate)
P/E
14.72 | 13.83
P/S
1.60 | 1.54
EV/Sales
1.26 | 1.21
EV/FCF
9.95
P/B
1.50
Dividends
DPS
€0.89
Yield 1Y | 5Y
1.21% | 0.81%
Growth 1Y | 5Y
4.71% | 18.56%
Payout 1Y | 3Y
17.87% | 18.49%
Increased
2 Years
Financials (TTM | estimate)
Revenue
€539.2m | €559.1m
EBITDA
€108.8m | €105.4m
EBIT
€76.8m
Net Income
€58.7m | €62.5m
Free Cash Flow
€68.2m
Growth (TTM | estimate)
Revenue
1.88% | 3.69%
EBITDA
5.47% | -3.45%
EBIT
7.37%
Net Income
5.63% | 6.56%
Free Cash Flow
-3.17%
Margin (TTM | estimate)
Gross
50.82%
EBITDA
20.18% | 18.85%
EBIT
14.24%
Net
10.88% | 11.19%
Free Cash Flow
12.64%
Financial Health
Equity Ratio
77.38%
Return on Equity
10.19%
ROCE
12.75%
ROIC
13.70%
Debt/Equity
0.04
More
EPS
€4.98
FCF per Share
€5.78
Short interest
-
Employees
2.52k
Rev per Employee
€210.00k
Show more

Is Vetoquinol a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Vetoquinol Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a Vetoquinol forecast:

8x Buy
73%
3x Hold
27%

Analyst Opinions

11 Analysts have issued a Vetoquinol forecast:

Buy
73%
Hold
27%

Financial data from Vetoquinol

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
539 539
2% 2%
100%
- Direct Costs 265 265
1% 1%
49%
274 274
3% 3%
51%
- Selling and Administrative Expenses 172 172
2% 2%
32%
- Research and Development Expense - -
-
-
109 109
5% 5%
20%
- Depreciation and Amortization 32 32
1% 1%
6%
EBIT (Operating Income) EBIT 77 77
7% 7%
14%
Net Profit 59 59
6% 6%
11%

In millions EUR.

Don't miss a Thing! We will send you all news about Vetoquinol directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Vétoquinol SA operates as a global animal health company. It supplies drugs and nonmedicinal products for the livestock (cattle and pigs) and pet (dogs and cats) markets. The firm designs, develops and sells veterinary drugs and non-medicinal products in Europe, the Americas and the Asia Pacific region. It also manufactures antibiotic, anti-inflammatory, cardiology, and nephrology drugs. The company was founded by Joseph Frechin in 1933 and is headquartered in Lure, France.

Head office France
CEO Matthieu Frechin
Employees 2,519
Founded 1962
Website www.vetoquinol.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today